Outcome of Imaging and Biopsy of BI-RADS Category 3 Lesions: Follow-Up Compliance, Biopsy, and Malignancy Rates in a Large Patient Cohort.
Dogan S PolatKanwal MerchantJody HayesLena OmarLindsay ComptonBasak E DoganPublished in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2022)
In our cohort, BI-RADS category 3 lesions had significantly higher biopsy rates compared with the small malignancy rate, all of which were identified at baseline or first follow-up. Overall patient follow-up compliance low. Imaging follow-up, especially at first 6-month time point, should be encouraged in BI-RADS 3 lesions, instead of upfront biopsies.